CSS
WHWK

Cubist Systematic Strategies’s Whitehawk Therapeutics WHWK Stock Holding History

Cubist Systematic Strategies’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-6,589
Closed -$20.8K – 3658
2024
Q4 		$20.8K Buy
6,589
+5,580
+553% +$12.6K ﹤0.01% 2838
2024
Q3 		$2.08K Sell
1,009
-3,865
-79% -$6.25K ﹤0.01% 2883
2024
Q2 		$7.12K Buy
+4,874
New +$9.03K ﹤0.01% 2810
2023
Q2 		– Sell
-60,381
Closed -$437K – 4419
2023
Q1 		$437K Buy
60,381
+45,441
+304% +$485K ﹤0.01% 2755
2022
Q4 		$192K Sell
14,940
-9,411
-39% -$123K ﹤0.01% 3601
2022
Q3 		$344K Buy
24,351
+8,813
+57% +$116K ﹤0.01% 3440
2022
Q2 		$191K Buy
15,538
+2,712
+21% +$40.3K ﹤0.01% 3731
2022
Q1 		$218K Buy
12,826
+1,851
+17% +$35.5K ﹤0.01% 3008
2021
Q4 		$265K Buy
+10,975
New +$276K ﹤0.01% 2888

Other funds holding WHWK

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Cubist Systematic Strategies's WHWK Position: Q1 2025 in Review

Cubist Systematic Strategies sold out of Whitehawk Therapeutics (WHWK) in Q1 2025, closing a stake of 6,589 shares — an estimated $20.8K sold.

Cubist Systematic Strategies first reported a position in WHWK in Q4 2021 and held it in 9 quarters. The position peaked at $437K in Q1 2023. 50 funds tracked by Wall St. Rank hold WHWK as of Q1 2025.

  • Cubist Systematic Strategies reported no remaining Whitehawk Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 6,589 Whitehawk Therapeutics shares in Q1 2025, an estimated $20.8K.
  • Cubist Systematic Strategies first reported a position in Whitehawk Therapeutics in Q4 2021 and held it in 9 quarters.
  • Cubist Systematic Strategies's Whitehawk Therapeutics position peaked at $437K in Q1 2023.
  • 50 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q1 2025.

Based on Cubist Systematic Strategies's 13F filing for Q1 2025, filed 15 May 2025.